Proton Beam Therapy For Prostate Cancer Survival Rate

Tumor control data the new study confirms similar results as the benchmark study for rate of tumor control in low risk both 99 percent and high risk prostate cancer 74.

Proton beam therapy for prostate cancer survival rate.

Patients with low to medium risk prostate cancer. Proton therapy is a type of radiation treatment. According to a study published in 2013 by the university of florida prostate cancer patients who received proton therapy treatment were found to be free of cancer progression for five years after their treatment. Proton therapy exhibits higher success rates in prostate cancer patients.

Discovery of prostate cancer at this stage is almost 80 with a 5 year survival rate of almost 100. Stage 2 prostate cancer divided into iia and iib stages the tumor may or may not be detectable through a physical examination or imaging tests and still has not spread outside of the prostate. Moreover the rate of serious gastrointestinal and urologic complications is low at 1. And high risk patients are 99 percent 99 percent and 76 percent respectively while overall survival rates are 93 percent 88 percent and 90 percent.

If detected early prostate cancer has a five year survival rate of nearly 99. Since then we have treated thousands of men who have prostate cancer with proton therapy. Proton therapy is a form of external beam radiation therapy that uses the positive charged particles of atoms protons to deliver targeted treatment in cancerous tumors. Proton therapy for prostate cancer results in long term patient survival and excellent quality of life.